GlycoPath Inc. Applies Proprietary Technology to Lyme Disease to Distinguish Among Disease States and Track Treatment Response ...Middle East

CHARLESTON, S.C., Oct. 21, 2022 /PRNewswire/ -- GlycoPath's proprietary GlycoTyper™ immunoaffinity technology was used to distinguish between Lyme disease infection states and track treatment response through a collaboration with Drexel University College of Medicine, Philadelphia, PA. Dr....

Hence then, the article about glycopath inc applies proprietary technology to lyme disease to distinguish among disease states and track treatment response was published today ( Friday 21/10/2022 - 05:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GlycoPath Inc. Applies Proprietary Technology to Lyme Disease to Distinguish Among Disease States and Track Treatment Response )

Also on site :

• Wayfair Has a 'Space-Saving' Shoe Rack on Sale for $47 That Makes Entryway Chaos Disappear
• 'The Last of Us' Star Gabriel Luna Honors Catherine O'Hara With Touching Tribute: 'Her Kindness Was as Gigantic as Her Genius'
• Anti-ICE protesters clash with police in ‘national shutdown’ (VIDEOS)